Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres








Gamme d'année
1.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;45(10): 929-934, Oct. 2012. ilus, tab
Article de Anglais | LILACS | ID: lil-647751

RÉSUMÉ

Lopap, found in the bristles of Lonomia obliqua caterpillar, is the first exogenous prothrombin activator that shows serine protease-like activity, independent of prothrombinase components and unique lipocalin reported to interfere with hemostasis mechanisms. To assess the action of an exogenous prothrombin activator reversing the anticoagulant and antihemostatic effect induced by low molecular weight heparin (LMWH), male New Zealand rabbits (N = 20, weighing 3.8-4.0 kg) allocated to 4 groups were anticoagulated with 1800 IU/kg LMWH (iv) over 2 min, followed by iv administration of saline (SG) or recombinant Lopap (rLopap) at 1 µg/kg (LG1) or 10 µg/kg (LG10), 10 min after the injection of LMWH, in a blind manner. Control animals (CG) were treated only with saline. The action of rLopap was assessed in terms of activated partial thromboplastin time (aPTT), prothrombin fragment F1+2, fibrinogen, and ear puncture bleeding time (BT) at 5, 10, 15, 17, 20, 30, 40, 60, and 90 min after initiation of LMWH infusion. LG10 animals showed a decrease of aPTT in more than 50% and BT near to normal baseline. The level of prothrombin fragment F1+2 measured by ELISA had a 6-fold increase with rLopap treatment (10 µg/kg) and was inversely proportional to BT in LMWH-treated animals. Thus, Lopap, obtained in recombinant form using E. coli expression system, was useful in antagonizing the effect of LMWH through direct prothrombin activation, which can be a possible strategy for the reversal of bleeding and anticoagulant events.


Sujet(s)
Animaux , Mâle , Lapins , Anticoagulants/usage thérapeutique , Coagulation sanguine/effets des médicaments et des substances chimiques , Hémorragie/traitement médicamenteux , Antagonistes de l'héparine/pharmacologie , Héparine bas poids moléculaire/antagonistes et inhibiteurs , Prothrombine/effets des médicaments et des substances chimiques , Serine endopeptidases/pharmacologie , Hémorragie/induit chimiquement
2.
J. venom. anim. toxins incl. trop. dis ; J. venom. anim. toxins incl. trop. dis;12(2): 156-171, 2006. tab
Article de Anglais | LILACS | ID: lil-434717

RÉSUMÉ

Lonomia obliqua caterpillar is frequently seen in accidents with humans especially in the south of Brazil. Patients develop a hemorrhagic syndrome that can be treated with specific antilonomic serum. A consumptive coagulopathy was found to be the main cause of bleeding complications observed in patients after contact with L. obliqua. Studies revealed that L. obliqua caterpillar bristle extract (LOCBE) displays a procoagulant activity that leads to intravascular thrombin formation, resulting in a special form of disseminated intravascular coagulation (DIC). Fibrinolysis seems to be secondary to the fibrin production, since no direct fibrinolytic activity was found in LOCBE. Two procoagulant toxins, a factor X activator (Losac) and a prothrombin activator (Lopap), were isolated from LOCBE and characterized. Infusion of Lopap into experimental animals triggered a condition similar to that observed in human envenomation


Sujet(s)
Animaux , Sérums antivenimeux/usage thérapeutique , Coagulation intravasculaire disséminée/complications , Lepidoptera , Papillons de nuit , Intoxication , Animaux venimeux , Anticoagulants
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE